US Stock MarketDetailed Quotes

HAO Haoxi Health Technology

Watchlist

7.430
+0.610+8.94%

Close May 28 16:00 ET

7.600
+0.170+2.29%

Post 18:33 ET

239.54MMarket Cap247.67P/E (TTM)

Haoxi Health Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

Total revenue

74.72%28.23M

25.76%16.16M

12.85M

Operating revenue

74.72%28.23M

25.76%16.16M

--12.85M

Cost of revenue

68.73%26.17M

26.68%15.51M

12.24M

Gross profit

217.87%2.06M

7.12%648.72K

605.58K

Operating expense

127.99%866.26K

38.15%379.95K

275.02K

Selling and administrative expenses

191.28%808.09K

30.63%277.43K

--212.38K

-Selling and marketing expense

-14.28%32.13K

-12.12%37.49K

--42.66K

-General and administrative expense

223.40%775.96K

41.38%239.94K

--169.72K

Research and development costs

-43.27%58.16K

63.66%102.52K

--62.65K

Operating profit

344.92%1.2M

-18.69%268.77K

330.55K

Net non-operating interest income expense

-109.84%-20.9K

-89.01%-9.96K

-5.27K

Non-operating interest expense

109.84%20.9K

89.01%9.96K

--5.27K

Other net income (expense)

1,866.50%15.5K

788

Other non- operating income (expenses)

1,866.50%15.5K

--788

----

Income before tax

358.56%1.19M

-20.19%259.6K

325.28K

Income tax

1,370.24%220.65K

-29.27%15.01K

21.22K

Net income

296.49%969.75K

-19.56%244.59K

304.07K

Net income continuous Operations

296.49%969.75K

-19.56%244.59K

--304.07K

Minority interest income

Net income attributable to the parent company

296.49%969.75K

-19.56%244.59K

304.07K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

296.49%969.75K

-19.56%244.59K

304.07K

Basic earnings per share

296.49%0.0664

67.41%0.0167

0.01

Diluted earnings per share

296.49%0.0664

67.41%0.0167

0.01

Dividend per share

Currency Unit

USD

USD

USD

Audit Opinions

Unqualified Opinion

--

--

	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021
Total revenue	74.72%28.23M	25.76%16.16M	12.85M
Operating revenue	74.72%28.23M	25.76%16.16M	--12.85M
Cost of revenue	68.73%26.17M	26.68%15.51M	12.24M
Gross profit	217.87%2.06M	7.12%648.72K	605.58K
Operating expense	127.99%866.26K	38.15%379.95K	275.02K
Selling and administrative expenses	191.28%808.09K	30.63%277.43K	--212.38K
-Selling and marketing expense	-14.28%32.13K	-12.12%37.49K	--42.66K
-General and administrative expense	223.40%775.96K	41.38%239.94K	--169.72K
Research and development costs	-43.27%58.16K	63.66%102.52K	--62.65K
Operating profit	344.92%1.2M	-18.69%268.77K	330.55K
Net non-operating interest income expense	-109.84%-20.9K	-89.01%-9.96K	-5.27K
Non-operating interest expense	109.84%20.9K	89.01%9.96K	--5.27K
Other net income (expense)	1,866.50%15.5K	788
Other non- operating income (expenses)	1,866.50%15.5K	--788	----
Income before tax	358.56%1.19M	-20.19%259.6K	325.28K
Income tax	1,370.24%220.65K	-29.27%15.01K	21.22K
Net income	296.49%969.75K	-19.56%244.59K	304.07K
Net income continuous Operations	296.49%969.75K	-19.56%244.59K	--304.07K
Minority interest income
Net income attributable to the parent company	296.49%969.75K	-19.56%244.59K	304.07K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	296.49%969.75K	-19.56%244.59K	304.07K
Basic earnings per share	296.49%0.0664	67.41%0.0167	0.01
Diluted earnings per share	296.49%0.0664	67.41%0.0167	0.01
Dividend per share
Currency Unit	USD	USD	USD
Audit Opinions	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

Recent IPOs